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EXECUTIVE SUMMARY  
Medicaid, the nation’s principal safety-net health insurance program for low-income Americans, has 
played a critical role for people with HIV from the early days of the AIDS epidemic in the 1980s and has 
remained so ever since.  Medicaid is estimated to be the single largest source of coverage for people with 
HIV in the U.S., and to account for more than half of all spending on HIV care by the federal government 
(including the state share of Medicaid spending) (see Figure).  
 
Despite the importance of Medicaid for 
people with HIV, there is a dearth of 
comprehensive and current information 
about its role for this population. Most studies 
conducted to date have been limited to small, 
non-representative samples or are outdated. 
This has significantly hampered the ability of 
policymakers and others to fully understand 
Medicaid’s role for people with HIV.  This gap 
is all the more important to fill given pending 
changes to the Medicaid program as a result 
of the Patient Protection and Affordable Care 
Act (The Affordable Care Act or ACA), which 
will significantly expand access to Medicaid 
for many people with HIV as of 2014. It is 
also important in light of the release of the 
first comprehensive National HIV/AIDS 
Strategy (NHAS) for the U.S., which includes 
“increasing access to care and improving 
health outcomes for people living with HIV” 
as one of three primary goals. 
 
This report provides new information about Medicaid and HIV based on analysis of data reported by all 
states to the federal government through the Medicaid Statistical Information System (MSIS).   Although 
Medicaid enrollees with HIV represent just a small fraction of the overall Medicaid population, they 
account for a significant share of people with HIV in regular care. Medicaid enrollees with HIV have a 
different demographic profile than enrollees without the disease and also have higher costs, even when 
compared to other high-cost enrollees groups such as the elderly and disabled, reflecting their care needs 
and the high cost of HIV care.  The role played by prescription drugs is significant, accounting for the 
largest share of spending by service for those with HIV.  Most enrollees with HIV qualify because they are 
permanently disabled and unable to work, and about three in 10 are also dually eligible for Medicaid and 
Medicare, a greater share than enrollees without the disease. Finally, the prevalence of mental illness 
and substance use, complex co-morbid conditions that often require more intensive and coordinated 
services, is much greater for those with HIV. Other key findings include: 
 
Enrollment and Demographics 
 There were 212,892 Medicaid enrollees with HIV in FY 2007, comprising a small fraction of the 
Medicaid population (<1%), but almost half (47%) of people with HIV estimated to be in regular care.  
 Whereas Medicaid enrollees with HIV are most likely to be male, black, and over the age of 19, as are 
people with HIV overall, Medicaid enrollees without HIV are most likely to be female, white, and under 
the age of 19. 
 Disability is by far the most common categorical eligibility pathway for people with HIV with three 
quarters (74%) qualifying for Medicaid as disabled. This is likely due to current federal Medicaid 
eligibility rules which categorically exclude non‐disabled adults without dependent children; as a result, 
low-income people with HIV typically cannot qualify for Medicaid until they become disabled. 
 A significant share of enrollees with HIV – about three in 10 (29%) – are dually eligible for both 
Medicaid and Medicare, compared to 19% of those without HIV.  Dual eligibles are among the most 
chronically ill and costly Medicaid enrollees, with many having multiple chronic conditions and 
$18.2 billion
Medicaid 
(federal & state 
combined)
$9.3 
(51%)
Medicare
$5.4 
(29%)
Ryan White
$2.3 (13%)
Veterans Affairs
$0.844 (5%)
SAMSHA
$0.137  (1%)
Other
$0.258 
(1%)
Federal Spending for HIV Care by Program 
(including state share of Medicaid), FY 2011
In Billions
NOTE: Other includes spending at DoJ, DoD, FEHB, and HHS Office of the Secretary. SOURCE: Kaiser Family Foundation, 
analysis of data provided by the Office of Management and Budget and Centers for Disease Control and Prevention, 2011. 
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requiring long-term care. Half of enrollees with HIV also had a co-occurrence of mental illness and/or 
substance use, compared to 22% of enrollees without HIV. 
 
Spending and Services 
 Spending on enrollees with HIV totaled $5.3 billion in FY 2007, about 2% of overall Medicaid 
spending. Prescription drugs accounted for the largest share of spending for enrollees with HIV (31%); 
by contrast, it was the smallest for enrollees without HIV (7%).  In addition, enrollees with HIV were 
significantly more expensive than their non–HIV positive counterparts, with per capita costs almost five 
times greater ($24,867 compared to $5091). This pattern holds across all eligibility categories.    
 The distribution of enrollees with and spending on HIV varies across the country, and differs from the 
distribution of HIV/AIDS prevalence. For example, while people with HIV overall are most likely to live 
in the South, the Northeast accounted for the largest share of Medicaid enrollees with HIV and 
spending for HIV.  The top 10 states by enrollment and spending were generally those with the 
greatest number of people living with the disease, although per capita spending varies significantly. 
 
These findings have important implications for policy.  First, they underscore the importance of Medicaid 
for people with HIV, confirming and updating prior estimates.  Second, they provide new information on 
Medicaid’s role for the population, particularly as compared to enrollees without HIV.  Finally, they serve 
as an important baseline from which to monitor the impact of the ACA.  Given Medicaid’s already critical 
role for those with HIV, one that is expected to expand significantly as of 2014, such information can help 
to inform ongoing efforts to increase access to care and improve health outcomes for people with HIV.   
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INTRODUCTION
Medicaid, the nation’s principal safety-net health insurance program for low-income Americans, has 
played a critical role for people with HIV since the beginning of the AIDS epidemic in the 1980s.1  Early 
on, Medicaid emerged as an increasingly important source of coverage for people with HIV.  At that time 
in the epidemic, there were no effective treatments available and most people with HIV became very sick 
quite quickly.  Often unable to work, they lost access to income and health insurance and became eligible 
for Medicaid.  As Medicaid financed an increasing share of HIV care, researchers coined the phrase, the 
“Medicaidization of AIDS”.2   
 
The emergence of effective, combination antiretroviral therapy a decade later dramatically changed the 
treatment landscape for HIV disease, reducing HIV-related illness and death significantly, and enabling 
people with HIV/AIDS to live longer and stay healthier.3,4  Yet these new treatments – the standard of HIV 
care today – are not a cure for HIV disease. Antiretroviral treatment is expensive and complex, and 
multiple other health services are needed to manage HIV disease which remains a disabling condition for 
many who often must turn to Medicaid for health insurance.  In addition, an increasing share of those 
newly affected by HIV are likely to be low income.5,6,7,8,9  As such, Medicaid continues to be a critical 
source of care for people with HIV/AIDS in the U.S., estimated to be their single largest source of 
coverage.10,11  It is also estimated to account for more than half of all federal spending on HIV care, when 
the state share of Medicaid spending is included.12 
 
Despite the importance of Medicaid for people with HIV disease, there is a dearth of information about its 
role for this population.  Most studies conducted to date have been limited to small, non-representative 
samples (e.g., a limited number of states, medical sites, or patient populations) and/or are outdated.11,13  
In fact, the only nationally representative study of people with HIV/AIDS in care ever conducted – the HIV 
Cost and Services Utilization Study (HCSUS)14 – is now nearly 15 years old.  As a result, even official 
federal government estimates of Medicaid spending on HIV care are based on these limited studies.15  
 
The lack of more comprehensive and current data has hampered the ability of policymakers and others to 
fully understand Medicaid’s role for people with HIV/AIDS. This gap is all the more important to fill given 
pending changes to the Medicaid program as a result of the Patient Protection and Affordable Care Act 
(The Affordable Care Act or ACA), which will significantly expand access to Medicaid for many people 
with HIV/AIDS as of 2014.  It is also important in light of the release of the first comprehensive National 
HIV/AIDS Strategy (NHAS) for the U.S., which includes “increasing access to care and improving health 
outcomes for people living with HIV” as one of three primary goals. Understanding Medicaid coverage for 
HIV is also timely given the announcement of new scientific evidence indicating that providing HIV 
treatment to people with HIV significantly reduces the risk of transmission to their negative partners.16,17  
This latter development underscores the importance providing access to HIV treatment, including through 
Medicaid, for this population. 
 
This report provides new information on Medicaid and HIV based on analysis of data reported by all 
states to the federal government through the Medicaid Statistical Information System (MSIS).  It examines 
national enrollment and spending patterns for Medicaid enrollees with HIV/AIDS, looking at key 
demographics, Medicaid eligibility pathways, spending by service, and other variables. It also compares 
the profile of Medicaid enrollees with HIV to their counterparts without HIV, as well as to the population of 
people living with HIV in the U.S.  Finally, it examines geographic distribution of enrollees with HIV, 
looking at data by region and state.  Taken together, this analysis not only provides new information on 
the extent of Medicaid’s role for people with HIV/AIDS, it also provides an important baseline from which 
to assess changes due to the implementation of ACA.  In addition, it demonstrates the feasibility of using 
MSIS for such an analysis, which has only recently begun to be utilized by federal officials for this 
purpose.18  
 
OVERVIEW OF MEDICAID19,20,21,22
Medicaid, the nation’s principal safety-net health insurance program for low-income Americans, covers 
health and long‐term care services for nearly 60 million low-income Americans and is the largest health 
coverage program in the country.  Medicaid is a means-tested entitlement program, jointly financed by the 
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federal and state governments and designed and administered by the states within broad federal 
guidelines.  As a result, there is significant variation across states in terms of eligibility criteria, benefits 
packages, and other aspects of the program.  Under health care reform, Medicaid’s role will expand and 
change in several significant ways.  A brief overview of current Medicaid eligibility criteria and services, as 
well as key changes expected as a result of the ACA, is provided below. 
 
 Eligibility. Under current law, to qualify for Medicaid, a person must be low-income, with limited 
assets, and belong to a group that is “categorically eligible”. There are “mandatory” eligibility groups, 
groups all states must cover in order to receive federal matching funds, and “optional” eligibility 
groups, groups states can choose to cover and receive federal matching funds.  Mandatory groups 
include: children; parents with dependent children; pregnant women; and most elderly and persons 
with disabilities who receive Supplemental Security Income (SSI), a program for which income 
eligibility equates to 75% of the federal poverty level (FPL) for an individual.  Disability is one of the 
main eligibility pathways for people with HIV.  People with HIV qualify as “disabled” under SSI criteria 
when their disease progresses to the point when they can no longer work or they transition to an 
AIDS diagnosis. Non‐disabled adults without dependent children are categorically excluded from 
Medicaid by federal law unless the state has a waiver or uses state‐only dollars to cover them. While 
many states have chosen to expand Medicaid eligibility beyond minimum federal eligibility standards, 
they have done so primarily for children, and eligibility for low income adults remains quite limited.   
States also have the option to cover the “medically needy,” categorically eligible individuals who 
exceed Medicaid’s financial criteria but have high medical costs (33 states and the District of 
Columbia currently have medically needy programs23). Finally, Medicaid plays an important role for 
many low-income Medicare enrollees, known as “dual eligibles,” by assisting them with their Medicare 
premiums and cost-sharing and covering key services that Medicare does not provide, such as long-
term care.   
 
 Services. Medicaid covers a broad range of services, many of which are critical for people with 
HIV/AIDS.  States must cover certain “mandatory” services, specified in federal law, in order to 
receive federal matching funds. These include inpatient and outpatient services, physician and nurse 
practitioner services; laboratory and x-ray services, and long-term care.  States may also cover 
services that federal law designates as “optional” and receive matching funds. Many of these optional 
services are particularly critical for people with HIV, such as prescription drugs, an optional benefit 
that all states cover. Other optional services include personal care services, home and community 
based care, and rehabilitation services.  States have broad flexibility in determining key aspects of 
their Medicaid benefits packages, including setting limits on the scope of services. For example, 
several states limit the number of prescriptions, hospital inpatient days, and physician visits allowed 
per month or year. States can also impose nominal cost-sharing for certain services.  Generally, the 
same Medicaid benefits package must be provided to all Medicaid enrollees statewide, although 
states can provide some groups with an alternate “benchmark” plan (which may be more or less 
limited). Medicaid benefits are offered on a fee-for-service basis, through managed care plans, or 
both.  Over the past two decades, state Medicaid programs have increasingly moved to Medicaid 
managed care, primarily for children and families, but more recently for other Medicaid populations as 
well, including the disabled.  Today, most Medicaid enrollees receive at least some of their care 
through managed care arrangements. 
 
 Health Care Reform.  Under health reform, Medicaid coverage will expand significantly. As of 2014, 
the program will be expanded to provide eligibility to nearly all people under age 65 with income 
below 133% FPL.  This means that Medicaid eligibility for people under the age of 65 will be based 
solely on income, and categorical eligibility criteria will be eliminated for this population.  This 
expansion is expected to significantly increase access to millions of low-income Americans, including 
many people with HIV, particularly those who are not yet disabled.  The ACA will eliminate a barrier to 
access that has presented a “Catch-22” for many people with HIV – although there are effective 
antiretroviral treatments that can help stave off disability and keep people with HIV healthier, they 
often cannot access Medicaid to receive these treatments until they are already sick and disabled. 
Also as part of the expansion, states will be required to provide most people who become newly 
eligible for coverage with benchmark benefits. The ACA made changes to the definition of benchmark 
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benefits, requiring them to provide all “essential health benefits,” which are the benefits that must be 
provided to people signing up for Exchange plans or coverage in the individual or small group 
insurance market, beginning in 2014. The HHS Secretary is charged with defining “essential health 
benefits,” which to date have not yet been finalized.24 A number of groups will be exempt from the 
requirement to enroll in the benchmark benefit plan, and will instead be offered the traditional 
Medicaid benefits plan, including the disabled already eligible for Medicaid, dual eligibles, pregnant 
women, the medically needy, and the medically frail. While non-disabled people with HIV are not 
specifically listed, they could fall into the medically frail category, which per final rules from HHS, 
must, at a minimum, include people with “serious and complex medical conditions.”25   
 
 
FINDINGS   
There were 212,892 Medicaid enrollees with 
HIV in FY 2007, accounting for <1% of the 
Medicaid population (see Figure 1). Although 
enrollees with HIV represent just a small 
fraction of the Medicaid population, they 
account for approximately a quarter (23%) of 
people who have been diagnosed with HIV 
in the U.S.26 and approximately 47% of those 
estimated to be in regular care27 (see 
Figures 2-3).  As such, Medicaid plays a 
bigger role for people with HIV than it does 
for the U.S. population overall (16% are 
covered by Medicaid)28, as well as for some 
other populations that also rely heavily on 
the program, including people with severe 
disabilities (20% are estimated to be covered 
by Medicaid) and diabetes (15%).19,29   
  
SOURCE: Kaiser Family Foundation, 2011. Analysis of  2007 MSIS data provided by the Urban Institute. 
Figure 1
Medicaid Enrollees with HIV as a Share of All 
Medicaid Enrollees, FY 2007
Enrollees with 
HIV
212,892
(<1%)
57.9 million
SOURCE: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the Urban Institute. 
Figure 3
Medicaid Enrollees with HIV as a Share of 
People with HIV in Regular Care, 2007
Enrollees 
with HIV
212,892
(47%)
N≈454,000
Figure 2
Medicaid Enrollees with HIV as a Share of 
People Diagnosed with HIV, 2007
Enrollees 
with HIV
212,892
(23%)
N≈908,000
SOURCES: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the Urban Institute and data from  
CDC, MMWR, 57(39), October 3, 2008, CDC, MMWR, 60(21), June 3, 2011, Gardner et.al., CID, 52(6), March 2011.
SOURCES: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the Urban Institute and data from 
CDC, MMWR, 57(39), October 3, 2008 and CDC, MMWR, 60(21), June 3, 2011. 
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Of the 212,892 enrollees with HIV/AIDS in FY 2007, 142,940 (67%) were enrolled for the full fiscal year, with full Medicaid 
benefits. This full-year group is used for some of the subgroup analyses and comparisons used in this report.30 Table 1 
provides a comparison of the demographic characteristics of full-year Medicaid enrollees with HIV/AIDS to people living 
with HIV in the U.S. Table 2 provides a comparison of enrollees with HIV compared to their counterparts on Medicaid 
without the disease.    
MEDICAID ENROLLEES WITH HIV 
Demographic Profile of Medicaid Enrollees with HIV  
The demographic profile of Medicaid enrollees with HIV differs from that of enrollees without the disease, 
reflecting in part the demographics of the HIV epidemic in the United States as well as current Medicaid 
eligibility rules.32 
    
 Gender.  The majority of Medicaid enrollees with HIV in FY 2007 were male (57%) and 43% were 
female.31  This is the opposite gender distribution of enrollees without HIV (57% were female and 
43%, male).  This difference reflects the demographics of the HIV epidemic, where three quarters of 
all people living with the disease are men.  At the same time, women with HIV are overrepresented 
on Medicaid relative to their share of people with HIV, reflective of current Medicaid rules which make 
it more difficult for men, particularly those without dependent children, to qualify for Medicaid (see 
Tables 1-2 and Figure 4). 
 
Table 1: Profile of Medicaid Enrollees with HIV 
Compared to Population of People with HIV 
  
Medicaid 
Enrollees with 
HIV
FY 2007 
People with 
HIV
200731
  
Male 57% 75% 
Female 43% 25% 
    
White 25% 35% 
Black 50% 46% 
Latino 17% 17% 
API/AI/AN 2% 2% 
Other 7% -- 
   
≤18 7% 2% 
19-44 42% 51% 
45-64 48% 44% 
65+ 3% 3% 
Total 142,940 ≈ 908,00026 
NOTES: Based on Analysis of Enrollees with Full-Year, Full-
Benefits Only. API=Asian/Pacific Islander; AI=American Indian; 
AN=Alaska Native; SOURCE: Kaiser Family Foundation, 2011. 
Analysis of 2007 MSIS data provided by the Urban Institute.
   
Table 2: Profile of Medicaid Enrollees with HIV  
Compared to Medicaid Enrollees without HIV 
  
Medicaid 
Enrollees with 
HIV
FY 2007 
Medicaid 
Enrollees w/o 
HIV
FY 2007 
  
Male 57% 43% 
Female 43% 57% 
     
White 25% 42% 
Black 50% 26% 
Latino 17% 20% 
API/AI/AN 2% 5% 
Other 7% 6% 
    
≤18 7% 56% 
19-44 42% 19% 
45-64 48% 13% 
65+ 3% 12% 
Total 142,940 27,922,836 
NOTES: Based on Analysis of Enrollees with Full-Year, Full-
Benefits Only. API=Asian/Pacific Islander; AI=American Indian; 
AN=Alaska Native; SOURCE: Kaiser Family Foundation, 2011. 
Analysis of 2007 MSIS data provided by the Urban Institute.
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 Race/Ethnicity. In FY 2007, half of enrollees with HIV were Black (50%), a quarter were white (25%) 
and 17% were Latino.  By contrast, most enrollees without HIV were white (42%), a quarter (26%) 
were Black, and 20% were Latino.  This is likely a reflection of the population living with HIV, 46% of 
whom are Black, a much greater share than in the U.S. population overall (13%).31  Small shares of 
enrollees were Asian-Pacific Islander, American Indian, or Alaska Native (see Tables 1-2 and Figure 
5). 
 
 Age.  The age distribution of Medicaid enrollees with HIV differs significantly from that of other 
Medicaid enrollees.  In FY 2007, almost all enrollees with HIV were between the ages of 19 and 64 
(90%), with those between the ages of 45 and 64 alone accounting for almost half (48%) of enrollees 
with HIV.  By contrast, the majority of enrollees without an HIV diagnosis were under the age of 19 
(56%); just 7% of Medicaid enrollees with HIV were under age 19.  Fewer enrollees with HIV are 
seniors (3%), compared to enrollees without the disease (12%).  The age distribution of enrollees with 
HIV is similar to that of people with HIV (see Tables 1-2 and Figure 6).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4
Medicaid Enrollees by Gender and 
HIV Status, FY 2007
43%
57%
57%
43%
Enrollees with HIV
142,940
All Other Enrollees
27,922,836
Male
Female
NOTE: Based on analysis of enrollees with full year, full benefits.  SOURCE: Kaiser Family Foundation, 2011.  
Analysis of 2007 MSIS data provided by the Urban Institute. 
Figure 5
Medicaid Enrollees by Race/Ethnicity and 
HIV Status, FY 2007
25%
42%
50%
26%
17% 20%
2% 5%
7% 6%
Enrollees with HIV
142,940
All Other Enrollees
27,922,836
Other/Unknown
API/AI/AN
Latino
Black
White
NOTE: Based on analysis of enrollees with full year, full benefits.  API = Asian-Pacific Islander; AI = American Indian; AN = 
Alaska Native. SOURCE: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the Urban Institute. 
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Eligibility Pathways for Enrollees with HIV   
As mentioned above, to qualify for Medicaid under current law, individuals must meet both financial 
eligibility criteria and be part of a group that is “categorically eligible”; non‐disabled adults without 
dependent children are categorically excluded from Medicaid by federal law, unless a state has a waiver 
or uses state‐only dollars to cover them.  Because people with HIV are more likely to be male33 and less 
likely to have dependent children than the population overall,34 they typically cannot qualify for Medicaid 
until they become disabled and receive Supplemental Security Income (SSI) benefits.  Indeed, this 
analysis finds that disability is by far most common categorical eligibility pathway for people with HIV and 
much more so than for enrollees without HIV disease.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6
Medicaid Enrollees by Age and 
HIV Status, FY 2007
7%
56%42%
19%
48%
13%
3%
12%
Enrollees with HIV
142,940
All Other Enrollees
27,922,836
65+
45‐64
19‐44
≤18
NOTE: Based on analysis of enrollees with full year, full benefits.  SOURCE: Kaiser Family Foundation, 2011.  
Analysis of 2007 MSIS data provided by the Urban Institute. 
Figure 7
Medicaid Enrollees by Eligibility Pathway and 
HIV Status, FY 2007
3% 12%
74%
22%
17%
13%
5%
53%
Enrollees with HIV
142,940
All Other Enrollees
27,922,836
Children
Non‐Disabled Adults
Disabled
Elderly
NOTE: Based on analysis of enrollees with full year, full benefits.  SOURCE: Kaiser Family Foundation, 2011.  
Analysis of 2007 MSIS data provided by the Urban Institute. 
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 In FY 2007, approximately three quarters (74%) of Medicaid enrollees with HIV qualified as a result of 
being disabled compared to just over one fifth (22%) of enrollees without HIV.  By contrast, many 
fewer enrollees with HIV were children (5%), the most common eligibility pathway for those without 
HIV (53%).  A smaller share of enrollees with HIV were elderly (3%) compared to enrollees without 
HIV (12%).  Only 17% of people with HIV and 12% of those without the disease qualified as non-
disabled adults, reflecting eligibility limitations for this group (See Figure 7). 
 
Dual Eligibles:  Medicaid & Medicare   
As mentioned above, Medicaid plays an important role for many low-income Medicare enrollees, known 
as “dual eligibles,” by assisting them with their Medicare premiums and cost-sharing and covering key 
services that Medicare does not provide, such as long-term care.19  Dual eligibles are among the most 
chronically ill and costly enrollees, with many having multiple chronic conditions and requiring long term 
care.  This analysis finds that a significant share of enrollees with HIV – about three in 10 (29%) – are 
dual eligibles, greater than those without HIV (19%) (see Figure 8).  This likely reflects the fact that 
Medicare enrollees with HIV are more likely to be low-income than Medicare enrollees without the 
disease, and thus need to rely on Medicaid for supplemental coverage.35  
Mental Illness & Substance Use: Dual/Triple Diagnoses  
Mental illness and substance use, conditions which are often co-occurring, require multiple and complex 
health services and present unique care challenges for those with other health conditions, including 
HIV.36  Studies have shown that people with HIV are more likely to also suffer from mental illness and/or 
substance use than the population overall.4,37  This appears to be the case for people with HIV on 
Medicaid as well.  In FY 2007, half of enrollees with HIV also had a diagnosis of mental illness and/or 
substance use, more than twice the share of enrollees without the disease (22%) (see Figure 9). 
 
Figure 8
Dual Eligibles: Medicaid Enrollees with Medicare 
Coverage by HIV Status, FY 2007
29%
19%
71%
81%
Enrollees with HIV
142,940
All Other Enrollees
27,922,836
Non‐Duals
Dual Eligibles
NOTE: Based on analysis of enrollees with full year, full benefits.  SOURCE: Kaiser Family Foundation, 2011.  
Analysis of 2007 MSIS data provided by the Urban Institute. 
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Medicaid Managed Care   
The shift to Medicaid managed care, particularly for children and families and more recently for the 
disabled, is seen among enrollees with HIV as well.  In FY 2007, 71% of enrollees with HIV had at least 
some of their care paid for through Medicaid managed care,38  although, as a population that primarily 
qualifies for Medicaid through disability, they were less likely to receive services through managed care 
than enrollees without HIV (85%).  
MEDICAID SPENDING ON 
ENROLLEES WITH HIV 
 
In FY 2007, Medicaid spending on 
enrollees with HIV—including both full-
year and part-year enrollees—totaled 
$5.3 billion. This represented 1.8% of 
overall Medicaid spending, a slightly 
greater share than their representation 
among all enrollees and indicative of the 
high costs of HIV care. Indeed, per capita 
spending for enrollees with HIV was 
$24,867, almost five times higher than for 
those without an HIV diagnosis ($5,091) 
(see Figure 10). Spending patterns for 
enrollees with HIV differed significantly 
from those without the disease, reflecting 
the different services used and their 
associated costs between the two 
groups.   
 
 
 
 
 
Figure 9
Medicaid Enrollees with Mental Illness and/or 
Substance Use by HIV Status, FY 2007
50%
22%
50%
78%
Enrollees with HIV
142,940
All Other Enrollees
27,922,836
No Mental Illness/
Substance Use
Mental Illness/
Substance Use
NOTE: Based on analysis of enrollees with full year, full benefits.  SOURCE: Kaiser Family Foundation, 2011.  
Analysis of 2007 MSIS data provided by the Urban Institute. 
Figure 10
Per Capita Spending for Medicaid Enrollees
by HIV Status, FY 2007
$24,867
$5,091
Enrollees with HIV
142,940
All Other Enrollees
27,922,836
SOURCE: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the Urban Institute. 
11
p. 11  
 
 
Spending by Service 
Spending patterns for enrollees with HIV were significantly different than their counterparts without the 
disease.39  Among enrollees with HIV, prescription drugs accounted for the largest share of spending of 
any service category (31%), followed by inpatient care (27%), and long-term care40 (17%).  Outpatient 
and other acute care accounted for smaller shares.41  By contrast, among enrollees without HIV, long 
term care accounted for the largest share of spending (38%), followed by other acute care (31%); 
prescription drugs account for just 7% of spending (see Figure 11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
While prescription drugs accounted for the largest share of spending by service category for enrollees 
with HIV, inpatient care, followed closely by long term care, accounted for the highest spending per user 
($22,341 and $21,168, respectively).  Per user spending on prescription drugs was the third highest, and 
Figure 11
Prescription 
Drugs
7%
Inpatient 
Services
12%
Long Term Care
38%
Other Acute
31%
Outpatient 
12%
Medicaid Spending for Enrollees by Type of 
Service and HIV Status, FY 2007
Enrollees with HIV
$5.3 billion
Prescription 
Drugs
31%
Inpatient 
Services
27%
Long Term Care
17%
Other Acute
13%
Outpatient
12%
All Other Enrollees 
$295.3 billion
Figure 12
Spending per Medicaid User with and without 
HIV by Type of Service, FY 2007
$1,244
$2,068
$911
$28,216
$7,711
$3,575
$3,987
$10,280
$21,168
$22,341
Outpatient
Other Acute
Prescription
Drugs
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SOURCE: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the Urban Institute. 
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about half the cost ($10,280).  By contrast, per user spending among enrollees without HIV was highest 
for long term care.   
 
Per user spending for enrollees with HIV was higher than that for enrollees without HIV for all services 
except long term care, where it was about a third less than enrollees without HIV.  The biggest difference 
in per user spending was on prescription drugs, which was eleven times higher for enrollees with HIV 
compared to their counterparts without the disease (see Figure 12).  
 
Enrollees with HIV also were much more likely to have used prescription drug services (75%) and 
outpatient care (88%) compared to their counterparts without the disease (45% and 58%).42 
 
 
Spending by Eligibility Pathway  
By eligibility category, per capita spending among enrollees with HIV was highest for the disabled, 
followed by the elderly.  Among those without HIV, per capita spending was highest for the elderly, 
followed by the disabled.  In general, this reflects the more intensive use of both acute and long‐term care 
services by both disabled and elderly Medicaid beneficiaries. Still, per capita spending per enrollee with 
HIV was higher in each eligibility category than for those without the disease (see Figure 13), given the 
complex care needs of those with HIV.  
 
 
 
 
 
 
 
 
 
Table 3 presents per capita spending by eligibility group and type of service.   As shown, spending per 
enrollee with HIV was higher in each eligibility group by type of service, compared to enrollees without 
HIV, with one exception – long term care spending per disabled enrollee without HIV was higher than 
long term care spending per disabled enrollee with HIV.  The biggest difference in spending per service 
between those with and without HIV was on prescription drugs, which was several times higher for those 
with HIV across all eligibility groups.    
 
Spending by Demographic Group 
Medicaid spending by demographic group was higher across the board for enrollees with HIV compared 
to their non-HIV counterparts.  There were also significant differences in per capita spending, particularly 
by race/ethnicity.  
 
 
Figure 13
Spending per Medicaid User with and without 
HIV by Eligibility Pathway, FY 2007
$26,639
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SOURCE: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the Urban Institute. 
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Table 3. Medicaid Spending Per User by Eligibility Pathway  
and Type of Service, FY 2007 
With HIV 
Without  
HIV
Elderly
Long Term Care   $30,167 $28,667  
Inpatient   $13,783 $3,954  
Outpatient/Physician/Clinic $2,245 $812  
Drugs   $3,402 $497  
Other Acute   $3,233 $2,746  
    
Disabled   
Long Term Care   $21,413 $33,796 
Inpatient   $23,800 $14,922 
Outpatient/Physician/Clinic $3,837 $2,668 
Drugs   $11,295 $2,636 
Other Acute   $4,381 $4,144 
        
Adults   
Long Term Care   $12,790 $1,947  
Inpatient   $19,386 $5,463  
Outpatient/Physician/Clinic $3,200 $1,154  
Drugs   $9,006 $550  
Other Acute   $3,181 $1,986  
        
Children   
Long Term Care   $12,469 $6,137  
Inpatient   $15,657 $6,085  
Outpatient/Physician/Clinic $2,168 $787  
Drugs   $5,492 $414  
Other Acute   $2,724 $1,442  
NOTE: Represents positive total spending for beneficiaries in each service category only, 
and does not include beneficiaries with total negative spending which would reflect 
adjustments for previous overpayments. SOURCE: Kaiser Family Foundation, 2011. 
Analysis of 2007 MSIS data provided by the Urban Institute.
Gender. Spending patterns by gender generally mirror the gender representation of enrollees with 
HIV.  Per capita spending is slightly higher for male enrollees with HIV than female, although in both 
cases, higher than their male and female counterparts without HIV.  
Race/Ethnicity. Spending on enrollees with HIV by race/ethnicity is also similar to their share of 
enrollment. Per capita costs for enrollees with HIV were highest for Latinos, followed by Blacks.  By 
contrast, per capita costs among enrollees without HIV were highest among whites. 
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Age. Spending by age group varies between those with and without HIV.  Per capita spending among 
enrollees with HIV was highest among the 45-64 year old age group, followed by the 19-44 year old 
age group.  By contrast, among those without HIV, per capita spending was highest among the 
elderly. This reflects different service use, and their associated costs, between the groups, as 
described above.  
Spending for Dual-Eligibles  
Among enrollees with HIV, dual eligibles accounted for a smaller share of spending (13%) than 
enrollment (29%).  By contrast, among those without HIV, duals accounted for a much higher share of 
spending (41%) than enrollment (19%).  In addition, per capita costs for duals with HIV were significantly 
less than for non-duals with HIV.  The opposite was true for those without the disease, where per capita 
expenditures were higher for duals than non-duals.  Finally, although per capita spending per enrollee 
with HIV was higher than for their non HIV counterparts overall and by eligibility group, it was lower for 
duals (see Figure 14).   
 
The lower per capita spending for dual eligibles with HIV appears to be due to the role of prescription 
drugs in HIV care and the implementation of the Medicare Part D prescription drug benefit in 2006, which 
shifted prescription drug costs from Medicaid to Medicare for all dual-eligibles. Given the critical role 
played by prescription drugs in HIV care – much more so than for people without the disease – this shift 
would be noticeable for this population; indeed, analysis of data for years prior to the implementation of 
Part D indicates that per capita expenditures for dual-eligibles with HIV were, at that time, on par with 
their non-dual counterparts.43 
 
 
 
Spending For Enrollees with HIV/AIDS & Mental Illness/Substance Use  
Finally, enrollees with HIV who also have a diagnosis of mental illness and/or substance use accounted 
for a greater share of expenditures (67%) than enrollment (50%) in FY 2007.  Their per capita 
expenditures were almost twice as high as other enrollees with HIV ($38,246 compared to $19,515), and 
more than twice as high as their non-HIV counterparts with diagnoses of mental illness and/or substance 
use ($17,288).   
Figure 14
Per Capita Spending for Dual and Non‐Dual 
Eligibles by HIV Status, FY 2007
$13,003
$35,353
$17,190
$5,762
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Enrollees with HIV
All Other Enrollees
SOURCE: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the Urban Institute. 
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Geographic Distribution  
There is regional and state-level variation in enrollment and spending for enrollees with HIV across the 
country, in part reflecting the distribution of HIV in the U.S. and in part reflecting other factors including 
state Medicaid eligibility criteria and benefits, availability of other, non-Medicaid sources of coverage and 
care, and state fiscal environments.44   
 
 
 
Table 4: Medicaid Enrollment & Spending by Region, FY 2007 
Enrollees with HIV  Enrollees without HIV 
Region Enrollees Spending 
People with 
HIV45   Region Enrollees Spending 
U.S.
Population46
      
Northeast 39% 52% 26%   Northeast 18% 28% 18% 
Midwest 11% 10% 12%   Midwest 19% 21% 22% 
South 36% 28% 42%   South 35% 32% 37% 
West 15% 11% 19%   West 28% 20% 23% 
SOURCES: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the Urban Institute and of data from CDC, HIV 
Surveillance Supplemental Report, 15(1), 2010 and U.S. Census, 2011.  
 
 
 
Medicaid Enrollees with HIV/AIDS and Spending by Region 
The distribution of enrollees with HIV, as well as their spending, 
varies by region, and also varies somewhat from the distribution 
of HIV prevalence by region and from that of enrollees without 
HIV. 
 
 Enrollment.  The Northeast accounted for the largest share 
of Medicaid enrollees with HIV (39%), followed by the South 
(36%).  The West accounted for 15% and the Midwest, 11%. 
This differs from the distribution of HIV prevalence by region, 
where the South accounts for the greatest share of those 
living with HIV (42%), followed by the Northeast (26%).  It 
also differs from the distribution of Medicaid enrollees 
without HIV, who do reflect the U.S. population distribution 
(see Table 4). 
 
 Spending.  The Northeast also accounted for the majority (52%) of all spending on enrollees with HIV, 
followed by the South (28%). Spending per enrollee with HIV was significantly higher in the Northeast 
compared to other regions.  The South, despite accounting for the second largest share of enrollees 
and expenditures, ranked third in spending per enrollee. Among those without HIV, spending per 
enrollee ranked similarly (see Tables 4 & 5). 
 
 
Medicaid Enrollees with HIV/AIDS by State 
Medicaid enrollment and spending for people with HIV are concentrated in those states with the greatest 
number of people living with the disease, although per capita spending varies significantly. Most of the top 
10 states by enrollment and spending for those with HIV also rank in the top 10 for enrollees without the 
disease (See Figures 15-18, and Appendix III). 
 
Table 5: Per Capita Medicaid Spending 
by Region and HIV Status, FY 2007 
Region 
Enrollees 
with HIV 
Enrollees 
without HIV 
Northeast $33,220  $7,614 
Midwest $23,232  $5,414 
South $19,249  $4,651 
West $18,007  $3,720 
SOURCES: Kaiser Family Foundation, 2011. 
Analysis of 2007 MSIS data provided by the 
Urban Institute and from CDC, HIV 
Surveillance Supplemental Report, 15(1), 
2010. 
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 Nine of the top 10 states by HIV prevalence also had the highest number of enrollees with HIV.  
These top 10 states accounted for 73% of enrollment. The top 10 enrollment states also ranked as 
top 10 for expenditures, collectively accounting for 81% of spending on enrollees with HIV.  Per capita 
spending varied by state, ranging from $7,719 in Arizona to $37,075 in New York, almost five times 
greater.   
 Seven of the 10 states with the greatest enrollment and spending on those with HIV also ranked 
among the top 10 for enrollees without HIV. Per capita spending for enrollees without HIV also varied 
across the states, although the difference between the highest and lowest per capita states was 
smaller (2.8 times).   
 While enrollees with HIV accounted for <1% of total Medicaid enrollment in most states, as they did 
nationally, they accounted for 1.2% of New York’s Medicaid population and 2.1% of DC’s.  Spending 
on enrollees with HIV ranged from 0.3% or less in several states to 4.7% of spending in Maryland, 
5.3% in New York, and 7.2 % in DC.  
 The share of women enrollees with HIV, which was 43% overall, ranged from 22% in Hawaii to 70% 
in Maine; in 11 states, women represented more than half of Medicaid enrollees with HIV.   
 Blacks, who accounted for 50% of Medicaid enrollees with HIV overall, ranged from just 2% of 
enrollees in Idaho to 92% in DC.  In 10 states, all located in the South, Blacks accounted for 60% or 
more of enrollees with HIV. 
 Children, who accounted for 7% of enrollees with HIV overall, accounted for more than 10% in six 
states.  
 The share of disabled enrollees with HIV, which averaged 73% across the country, ranged from 37% 
in Maine to 97% in Idaho.  In nine states, the disabled account for 90% or more of enrollees with HIV.  
Non-disabled adult enrollees with HIV, who accounted for 17% of enrollees with HIV overall, 
accounted for no enrollees in Montana, but 43% of enrollees in Maine.      
 
  
Figure 15
Share of National HIV/AIDS Prevalence, 
Top 10 States, 2007
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Figure 16
Share of National Medicaid Enrollees with HIV,
Top 10 States, FY 2007
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SOURCE: CDC, HIV/AIDS Surveillance Report, 15(1), 2010. SOURCE: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the Urban Institute. 
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POLICY IMPLICATIONS & CONCLUSION 
This analysis confirms and expands upon prior studies which found Medicaid to play a significant role for 
people with HIV.  It also provides new national and state-level data on Medicaid and HIV, including 
comparisons between enrollees with and without the disease.  As it shows, although Medicaid enrollees 
with HIV represent just a small fraction of the Medicaid population, they account for almost half of people 
with HIV in regular care in the United States.   
 
Medicaid enrollees with HIV differ from their counterparts without the disease in many ways, in part 
reflecting the demographics of the epidemic but also HIV-related care needs, particularly a heavy reliance 
on prescription drugs, as well as current Medicaid eligibility rules.  For example, whereas Medicaid 
enrollees without HIV are most likely to be female, white, and under the age of 19, enrollees with HIV are 
most likely to be male, black, and over the age of 19, as are people with HIV overall.  Disability is by far 
the most common categorical eligibility pathway for people with HIV – approximately three quarters of 
enrollees with HIV are disabled, compared to about a fifth of enrollees without HIV.  This is likely due to 
current Medicaid eligibility rules which categorically exclude non‐disabled adults without dependent 
children from Medicaid under federal law; as a result, low-income people with HIV often cannot qualify for 
Medicaid until they become disabled.  
 
Spending patterns are also quite different for enrollees with HIV, who are significantly more expensive 
than their non–HIV positive counterparts, even those who are also disabled. Per capita spending on 
enrollees with HIV was almost five times higher than for those without HIV overall, and, for those who 
were disabled, almost twice that of their non-HIV positive counterparts.  A big difference between 
enrollees with and without HIV was service mix.  Prescription drugs accounted for the largest share of 
spending of any service category for enrollees with HIV; it was the smallest for enrollees without HIV.  
Enrollees with HIV were also more likely to be dual eligibles than their non-HIV counterparts, and had a 
much higher co-occurrence of mental illness and substance use.  
   
Finally, there is regional and state-level variation in enrollment and spending patterns for enrollees with 
HIV across the country.  The variation generally reflects the geographic distribution of the HIV epidemic, 
but also other factors including state Medicaid eligibility criteria and benefits.  For example, while people 
with HIV overall are most likely to live in the South, the Northeast accounted for the largest share of 
Medicaid enrollees with and spending for HIV.       
 
Figure 17
Share of National Medicaid Spending on HIV,
Top 10 States, FY 2007
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Figure 18
Medicaid Spending per Enrollee with HIV,
Top 10 States, FY 2007
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These findings have several implications for research and policy.  First, this study underscores the 
important role played by Medicaid for people with HIV, and as such, further analysis of these data could 
yield additional information on a substantial share of people living with HIV in care.  Additional analyses 
could explore areas such as: the quality of care received by enrollees with HIV, a critical area that could 
not be assessed by the current analysis; variations in spending by service for different groups of enrollees 
with HIV; and the variation in Medicaid HIV enrollment and spending across the country, which cannot 
fully be explained by HIV prevalence alone.     
 
Finally, these findings can serve as a baseline for monitoring the impact of health care reform, which is 
expected to significantly change this picture in 2014.  At that time, many more low income people with 
HIV will be able to qualify for Medicaid without having to be disabled, which has in the past presented a 
barrier to their access.  However, these findings suggest several issues that warrant particular attention in 
the context of HIV.  First, it is likely that the newly eligible population of people with HIV will have higher 
expenses and more complex needs than their counterparts without HIV; understanding more about them, 
including whether they differ from traditional enrollees with HIV as well as other enrollees without the 
disease, will be critical.  Second, it will also be important to assess how new opportunities presented by 
health care reform for care and service delivery coordination for populations with complex health care 
needs (e.g., medical homes, expanded home and community based services) will benefit enrollees with 
HIV.  This will be particularly critical given the high prevalence of substance use and mental illness found 
among current Medicaid enrollees with HIV, as well as the higher share who are dually eligible for 
Medicare, relative to those without HIV.  In addition, given the uneven distribution of enrollees with HIV 
across the country, it will be important to assess whether there is adequate provider capacity to serve an 
expanded population going forward.  Finally, given the complex and multiple care needs of people with 
HIV, it will be important to assess the comprehensiveness of Medicaid benefits, including the essential 
health benefits package, as implemented by states under health care reform. 
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APPENDIX I: DATA SOURCES AND METHODS     
 
The  data  used  in  this  analysis  come  from  the  Medicaid  Statistical  Information  System  (MSIS)  
Summary  File  maintained  by  the  Centers  for  Medicare  and  Medicaid  Services  (CMS) and provided 
to the Kaiser Family Foundation and the Urban Institute through a data use agreement, after personal 
identifiers were removed.  The current analysis focuses on MSIS data for the fiscal year (FY) 2007.  MSIS  
contains  demographic,  eligibility,  and  expenditure  information  for  all  Medicaid  enrollees, reported by 
states to CMS on an annual basis.    Enrollees are designated using their  Basis  of  Eligibility  in  MSIS  
as:  elderly  (age  65  and  older);  disabled  under  age  65; non-disabled  adults; and non-disabled 
children.  Expenditures  reported  in  MSIS  do  not  include  disproportionate  share  payments  to  
providers,  payments  to  Medicare,  or  administrative  payments.    Individuals  in  MSIS  are  classified  
by  the  level  of  benefits  they  receive, either full-benefit (entitled  to  the  full  scope  of  Medicaid  
benefits) or partial-benefit (entitled to only  a  subset  of  services,  such  as  pregnancy-related  or  
substance  abuse-services) and whether they are full-year or part-year enrollees.  As  restricted  benefit 
and part-year  enrollees  often  display  notably  different  patterns  of  spending  from  full-benefit, full-
year  enrollees, some of the analyses were limited to full-benefit, full-year enrollees only.  Enrollees  in  
both  fee-for-service  Medicaid  and  Medicaid  managed  care  plans were included,  unless  otherwise  
noted.     
 
To identify enrollees with an HIV-related diagnosis, a “flag” created by CMS containing standard ICD-9 
diagnosis codes for HIV disease was used.  This flag captures any enrollee with at least one of these 
ICD-9 codes.  There are some potential limitations to this analysis, including possible mis- or under-
reporting of diagnosis codes although there are no data to suggest that this occurs at higher rates for 
those with HIV than those without HIV. In addition, because MSIS disease flags only  capture individuals  
who  received  a service in FY 2007,  individuals  with  diagnosed  HIV  but  no service use in  the study 
year would not be included. The analysis also excludes anyone who has HIV that has not yet been 
diagnosed, estimated by the CDC to be approximately 20% nationally, although this population was not 
the focus of this study. Finally, it is important to note that the standard CMS flag used for HIV includes 
one ICD-9 diagnosis code (V01.7) that is not necessarily indicative of an HIV diagnosis; rather, it is used 
for exposure to HIV and other viral diseases. As such, some individuals without HIV may have been 
included in the analysis (we were unable to disaggregate by individual diagnosis code).  However, 
preliminary analysis of data from CMS for FY 2008 indicates that this is highly unlikely, as enrollees with 
such a code (regardless of whether they also had an HIV-related claim) accounted for less than 1% of 
paid claims by enrollees with any HIV flag.47 
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APPENDIX II  
 
Medicaid Enrollees with HIV, FY 2007 
Enrollees Spending Spending 
per 
Enrollee # % $ %
Female 62,096 43% $1,783,932,830 43% $28,729 
Male 80,843 57% $2,354,702,162 57% $29,127 
            
≤18 9,587 7% $200,508,008 5% $20,915 
19-44 60,357 42% $1,549,393,363 37% $25,670 
45-64 68,631 48% $2,272,482,183 55% $33,112 
65+ 4,364 3% $116,251,440 3% $26,639 
            
White 35,811 25% $867,044,045 21% $24,212 
Black 70,987 50% $2,152,336,972 52% $30,320 
Latino 24,527 17% $792,361,491 19% $32,306 
API/AI/AN 2,227 2% $53,027,473 1% $23,811 
Other 9,388 7% $273,921,284 7% $29,178 
            
Dual Eligibles 40,925 29% $532,141,989 13% $13,003 
Non-Duals 102,015 71% $3,606,549,276 87% $35,353 
            
Elderly            4,364 3% $116,251,440 3% $26,639 
Disabled        106,474 74% $3,337,463,997 81% $31,345 
Adults          24,792 17% $580,477,782 14% $23,414 
Children            7,310 5% $104,498,047 3% $14,295 
            
Mental Illness/Substance Use 72,029 50% $2,754,834,581 67% $38,246 
No Mental Illness/Substance Use            70,911 50% $1,383,856,683 33% $19,515 
NOTES: Based on Analysis of Enrollees with Full-Year, Full-Benefits Only. API=Asian/Pacific Islander; AI=American 
Indian; AN=Alaska Native; SOURCE: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the 
Urban Institute. 
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APPENDIX III 
 
Medicaid Enrollees without HIV, FY 2007 
Enrollees Spending Spending 
per 
Enrollee # % $ %
Female     15,786,543 57% $127,033,669,234 57% $8,047 
Male   12,127,067 43% $94,207,106,755 43% $7,768 
            
≤18 15,670,612 56% $55,081,489,097 25% $3,515 
19-44 5,368,096 19% $52,569,570,156 24% $9,793 
45-64 3,501,987 13% $54,779,799,951 25% $15,642 
65+ 3,374,496 12% $58,815,745,534 27% $17,429 
            
White 11,735,872 42% $120,875,370,470 55% $10,300 
Black 7,197,346 26% $46,812,294,440 21% $6,504 
Latino 5,692,875 20% $26,948,615,748 12% $4,734 
API/AI/AN 1,514,943 5% $9,344,124,076 4% $6,168 
Other 1,781,800 6% $17,275,143,939 8% $9,695 
            
Dual Eligibles 5,281,145 19% $90,783,824,236 41% $17,190 
Non-Duals 22,641,691 81% $130,471,724,438 59% $5,762 
  
  
3,374,506 12% $58,815,874,522  27% $17,429 
Elderly     6,235,750 22% $107,606,683,484 49% $17,256 
Disabled     3,518,152 13% $15,698,278,142 7% $4,462 
Adults   14,794,428 53% $39,134,712,526 18% $2,645 
Children 
  
6,068,094 22% $104,905,212,388 47% $17,288 
    21,854,742 78% $116,350,336,286 53% $5,324 
Mental Illness/Substance Use     15,786,543 57% $127,033,669,234 57% $8,047 
No Mental Illness/Substance Use   12,127,067 43% $94,207,106,755 43% $7,768 
NOTES: Based on Analysis of Enrollees with Full-Year, Full-Benefits Only. API=Asian/Pacific Islander; AI=American 
Indian; AN=Alaska Native; SOURCE: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the 
Urban Institute. 
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APPENDIX IV: Medicaid Enrollment and Spending on HIV, by State, FY 2007  
 State 
Enrollees
with HIV 
% of Total State 
Medicaid Enrollment 
Spending on 
Enrollees with HIV 
% of Total State 
Medicaid Spending 
Spending 
Per Capita 
Alabama 2,090 0.2% $21,764,143 0.6% $10,413 
Alaska 184 0.2% $5,395,801 0.6% $29,325 
Arizona 2,744 0.2% $21,181,671 0.3% $7,719 
Arkansas 872 0.1% $11,174,564 0.4% $12,815 
California 23,350 0.2% $454,079,420 1.4% $19,447 
Colorado 767 0.1% $14,356,786 0.5% $18,718 
Connecticut 2,910 0.5% $74,422,955 1.9% $25,575 
Delaware 1,381 0.7% $22,505,637 2.2% $16,297 
District Of Columbia 3,457 2.1% $93,683,093 7.2% $27,100 
Florida 18,691 0.7% $366,465,754 2.9% $19,607 
Georgia 6,743 0.4% $112,251,523 1.7% $16,647 
Hawaii 475 0.2% $6,619,833 0.6% $13,936 
Idaho 121 0.1% $2,393,379 0.2% $19,780 
Illinois 7,804 0.3% $272,636,487 2.2% $34,935 
Indiana 1,956 0.2% $27,425,223 0.6% $14,021 
Iowa 724 0.2% $6,747,593 0.3% $9,320 
Kansas 520 0.1% $8,320,108 0.4% $16,000 
Kentucky 903 0.1% $11,734,825 0.3% $12,995 
Louisiana 4,015 0.4% $79,656,988 1.8% $19,840 
Maine 1,076 0.3% $10,445,732 0.5% $9,708 
Maryland 7,719 1.0% $244,107,534 4.7% $31,624 
Massachusetts 7,364 0.5% $158,836,084 1.5% $21,569 
Michigan 1,640 0.1% $34,160,199 0.4% $20,829 
Minnesota 1,449 0.2% $28,478,041 0.5% $19,654 
Mississippi 2,060 0.3% $28,034,596 0.9% $13,609 
Missouri 2,580 0.3% $47,396,962 0.8% $18,371 
Montana 114 0.1% $2,209,356 0.3% $19,380 
Nebraska 342 0.1% $4,454,473 0.3% $13,025 
Nevada 818 0.3% $14,895,307 1.3% $18,209 
New Hampshire 221 0.2% $3,888,335 0.4% $17,594 
New Jersey 7,262 0.8% $205,146,807 2.8% $28,249 
New Mexico 415 0.1% $4,849,889 0.2% $11,686 
New York 59,455 1.2% $2,204,312,023 5.3% $37,075 
North Carolina 6,649 0.4% $128,514,757 1.4% $19,328 
North Dakota 39 0.1% $346,631 0.1% $8,888 
Ohio 3,973 0.2% $74,015,077 0.6% $18,630 
Oklahoma 1,068 0.1% $19,402,948 0.6% $18,168 
Oregon 934 0.2% $14,599,263 0.5% $15,631 
Pennsylvania 2,765 0.1% $47,175,005 0.3% $17,061 
Rhode Island 828 0.4% $20,038,124 1.2% $24,201 
South Carolina 3,144 0.4% $52,399,388 1.4% $16,666 
South Dakota 96 0.1% $2,953,459 0.5% $30,765 
Tennessee 3,535 0.2% $62,292,459 0.9% $17,622 
Texas 9,805 0.2% $161,893,709 0.9% $16,511 
Utah 219 0.1% $3,525,353 0.3% $16,098 
Vermont 199 0.1% $2,397,566 0.3% $12,048 
Virginia 3,207 0.4% $35,079,486 0.7% $10,938 
Washington 2,341 0.2% $40,295,937 0.7% $17,213 
West Virginia 432 0.1% $7,555,710 0.4% $17,490 
Wisconsin 1,400 0.1% $16,328,573 0.3% $11,663 
Wyoming 36 0.0% $1,162,073 0.3% $32,280 
Total 212,892 0.4% 5,294,006,640 1.8% $24,867 
SOURCE: Kaiser Family Foundation, 2011. Analysis of 2007 MSIS data provided by the Urban Institute. 
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